Enteroenterostomy of afferent pancreaticobiliary drainage limb.
Placement of a feeding jejunostomy tube into the afferent limb distal to the stomach.
History of Present Illness: 62 yo F w/ metastatic pancreatic cancer s/p Whipple procedure in [**2131**] currently C1D19 Gemcitabine presenting with 2-3 weeks of leg swelling.
Per her oncologist, the swelling preceded initiation of gemcitabine chmotherapy.
Past Medical History: Ms. [**Known lastname 14840**] has chronic pancreatitis with exocrine and endocrine insufficiency, status post Whipple surgery by Dr. [**Last Name (STitle) 468**] in [**9-22**].
Pathology from this surgery revealed chronic pancreatitis as well as low-grade dysplasia, pancreatic intraepithelial neoplasm.
She started C1 Gemcitabine on [**2136-3-1**].
S/P Whipple in [**9-22**].
Now with exocrine and endocrine dysfunction.
Persistently thrombosed splenic vein with heterogeneous enhancement of the spleen.
Following admission, patient underwent work-up for lower extremity edema.
Following discussion with patient and family regarding pursuing comfort measures care versus surgical decompression, patient opted to undergo surgical intervention.
Enteroenterostomy of afferent pancreaticobiliary drainage limb was performed, along with placement of a feeding jejunostomy tube into the afferent limb distal to the stomach.
IVC filter was placed on the firt post-operative day.
Her post-operative course was complicated by hypothermia, hyponatremia, and hypoglycemia.
She was treated with a 7-day course of peri-operative prophylactic anbtibiotics.
She was treated with normal saline, NaCl tablets and free water restriction.
She was treated with albumin infusion with concomitant lasix x 3 days with good result.
Leg edema was complicated by 4 areas of stage II skin breakdown over her distal lower extremities.
Leg edema improved with elevation of her extremities.
Lovenox was temporarily discontinued and heparin dependent antibody was sent.
Heparin dependent antibody returned with negative result.
A second test was pending at the time of discharge, and Lovenox was resumed.
4) Pancreatic insufficiency - Patient is s/p whipple with insulin dependence.
Prior to her surgical intervention, she was found unresponsive with a blood glucose of 11; it is unknown how long she had been hypoglycemic.
This event occurred after receiving Lantus 3 units.
All insulin was discontinued following this event.
Following transfer back to the Oncology service, her blood glucoses were persistently between 300-500, and she was restarted on a Humalog sliding scale.
5) Pancreatic cancer - Further chemotherapy deferred until completion of wound healing and pending further discussion with her Oncologist.
6) Pain control - She was managed with PRN Dilaudid in the peri-operative period.
She was later transitioned to her previous regimen of MScontin once able to swallow pills.
Given her minimal subcutaneous tissue for medication administration, she was maintained on Lovenox at prophylaxis dosing.
Lovenox was temporarily held with concern for HIT but was resumed prior to discharge.
She is was maintained on PPI as GI prophylaxis and Acyclovir as HSV prophylaxis given her immunocompromised status.
During her surgical procedure, placement of a feeding jejunostomy tube into the afferent limb distal to the stomach was accomplished.
Per recommendations from Nutrition consultant, she was titrated to tube feed goal of full-strength Impact at 35 cc/hour.
9) Skin breakdown: Wound care consultant recommends foam dressing to partial-thickness breakdown of coccyx with change q 3 days.
Recommend Adaptic non-adherent dressing, covered with dry gauze and Kerlex wrap, no tape on skin.
Medications on Admission: MSCONTIN 30 [**Hospital1 **] Percocet for breakthrough Lantus 3 qhs Humalog [**2141-3-29**] Compazine Creon Fluconazole 200 daily Acyclovir 400 tid Nystatin  Discharge Medications: 1.
Fluconazole 200 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours).
Therapeutic Multivitamin     Liquid Sig: Five (5) ML PO DAILY (Daily).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Albuterol 90 mcg/Actuation Aerosol Sig: Two (2) Puff Inhalation Q4H (every 4 hours) as needed.
Ipratropium Bromide 17 mcg/Actuation Aerosol Sig: Two (2) Puff Inhalation Q6H (every 6 hours).
Amylase-Lipase-Protease 33,200-10,000- 37,500 unit Capsule, Delayed Release(E.C.)
Acyclovir 400 mg Tablet Sig: One (1) Tablet PO every eight (8) hours.
Nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID (4 times a day).
Lantus 100 unit/mL Solution Sig: Two (2) units Subcutaneous qAM.
Morphine 30 mg Tablet Sustained Release Sig: One (1) Tablet Sustained Release PO Q12H (every 12 hours).
Humalog 100 unit/mL Solution Sig: Per sliding scale Subcutaneous qACHS.
Sodium Chloride 1 g Tablet Sig: Two (2) Tablet PO Q6 ().
Hydromorphone 2 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for breakthrough pain.
Lovenox 30 mg/0.3 mL Syringe Sig: One (1) syringe Subcutaneous once a day.
YOUR STAPLES CAN BE REMOVED ON [**2136-4-10**].
Followup Instructions: You are scheduled to follow-up with Dr. [**Last Name (STitle) **] in the Deparment of Surgery on [**2136-4-20**] at 9 a.m. His office is located on the [**Location (un) **] of the [**Hospital Ward Name 23**] Building on the [**Hospital1 18**] [**Hospital Ward Name 516**].
